Assignee
BIOLEGEND INC
US·12 granted patents·20 pending applications·29 citations·filing 2016–2025
Top patents by PatentIndex Score
32 records- 0195US10585088B2Stable nanomagnetic particle dispersionsBIOLEGEND INC·Filed 2016·Granted Mar 10, 2020·13 cites·18 claims
- 0293US11155714B2Substituted polyfluorene compoundsBIOLEGEND INC·Filed 2019·Granted Oct 26, 2021·8 cites·13 claims
- 0391US11584883B2Conjugated polymers and methods of useBIOLEGEND INC·Filed 2019·Granted Feb 21, 2023·4 cites·23 claims
- 0490US11630104B2Stable nanomagnetic particle dispersionsBIOLEGEND INC·Filed 2019·Granted Apr 18, 2023·3 cites·4 claims
- 0589US12091554B2Substituted polyfluorene compoundsBIOLEGEND INC·Filed 2021·Granted Sep 17, 2024·1 cites·12 claims
- 0684US2024360319A1Substituted polyfluorene compoundsBIOLEGEND INC·Filed 2024·Application pending·0 cites
- 0781US12461095B2Stable nanomagnetic particle dispersionsBIOLEGEND INC·Filed 2023·Granted Nov 4, 2025·0 cites·8 claims
- 0879US2025297156A1Conjugated polymers and methods of useBIOLEGEND INC·Filed 2025·Application pending·0 cites
- 0976US12384964B2Conjugated polymers and methods of useBIOLEGEND INC·Filed 2022·Granted Aug 12, 2025·0 cites·15 claims
- 1072US2023272344A1Compositions and methods for performing magnetibuoyant separationsBIOLEGEND INC·Filed 2023·Application pending·0 cites
- 1171US2026043811A1Methods for detecting meteorin-beta activityBIOLEGEND INC·Filed 2025·Application pending·0 cites
- 1271US2026043812A1Methods for detecting meteorin-beta activityBIOLEGEND INC·Filed 2025·Application pending·0 cites
- 1363US2026079168A1Tau phospho (thr217) binding antibodies and antigen binding fragments thereofBIOLEGEND INC·Filed 2025·Application pending·0 cites
- 1462US2025313650A1Chi3l1 binding antibodies and antigen binding fragments thereofBIOLEGEND INC·Filed 2025·Application pending·0 cites
- 1562US2024145035A1Analyzing per-cell co-expression of cellular constituentsBIOLEGEND INC·Filed 2023·Application pending·0 cites
- 1662US2026085128A1Anti-cd157 antibodies, antigen-binding fragments thereof and compositions and methods for making and using the sameBIOLEGEND INC·Filed 2023·Application pending·0 cites
- 1761US2024125806A1Phosphatidylserine binding agents for the detection and depletion of phosphatidylserine positive cellsBIOLEGEND INC·Filed 2023·Application pending·0 cites
- 1859US2026042848A1Anti-axl antibodies, antigen-binding fragments thereof and methods for making and using the sameBIOLEGEND INC·Filed 2023·Application pending·0 cites
- 1958US11608489B2Compositions and methods for performing magnetibuoyant separationsBIOLEGEND INC·Filed 2017·Granted Mar 21, 2023·0 cites·14 claims
- 2057US12455290B2Methods for detecting meteorin-β activityBIOLEGEND INC·Filed 2021·Granted Oct 28, 2025·0 cites·15 claims
- 2156US2025226059A1Visualizing intra-cell co-expression of cellular constituents using dimensionality reduction that is weighted by cell typeBIOLEGEND INC·Filed 2025·Application pending·0 cites
- 2256US2025052767A1Cd28 binding antibodies and antigen binding fragments thereofBIOLEGEND INC·Filed 2022·Application pending·0 cites
- 2353US2025382358A1Methods and compositions relating to mouse monoclonal anti-g4s linker antibodiesBIOLEGEND INC·Filed 2025·Application pending·0 cites
- 2451US2023193246A1Methods and compositions for detecting targetsBIOLEGEND INC·Filed 2021·Application pending·0 cites
- 2546US2024360228A1Anti-ccr8 antibodies, antigen-binding fragments thereof, and agents and compositions and methods for making and using the sameBIOLEGEND INC·Filed 2022·Application pending·0 cites
- 2645US2023054169A1Anti-tlr7 agents and compositions and methods for making and using the sameBIOLEGEND INC·Filed 2022·Application pending·0 cites
- 2744US2025093339A1Compositions and methods for enhanced sample multiplexingBIOLEGEND INC·Filed 2022·Application pending·0 cites
- 2842US2025341514A1Compositions for use with multiple fluorophores and methods of usingBIOLEGEND INC·Filed 2025·Application pending·0 cites
- 2942US2025341516A1Compositions for use with multiple fluorophores and methods of usingBIOLEGEND INC·Filed 2025·Application pending·0 cites
- 3040US12590973B2Uses of IL-40 and methods for detecting IL-40 activityBIOLEGEND INC·Filed 2021·Granted Mar 31, 2026·0 cites·17 claims
- 3140US12006363B2Anti-tetraspanin 33 agents and compositions and methods for making and using the sameBIOLEGEND INC·Filed 2020·Granted Jun 11, 2024·0 cites·9 claims
- 3239US12441806B2Anti-TLR9 agents and compositions and methods for making and using the sameBIOLEGEND INC·Filed 2021·Granted Oct 14, 2025·0 cites·5 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →